QTRX - Quanterix - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74766Q1013
Protein Detection Platforms, Immunoassay Instruments, Assays, Reagents
Quanterix Corporation is a life sciences company that focuses on developing and marketing innovative digital immunoassay platforms to advance precision health. These platforms are designed to support life sciences research and diagnostics across various regions, including North America, Europe, the Middle East, Africa, and the Asia Pacific.
The company's product portfolio includes the HD-X instrument, a cutting-edge protein detection platform, and the SR-X instrument, which enables researchers to apply Simoa detection in a broader range of applications. Additionally, Quanterix offers the SP-X instrument, built on Simoa planar array technology, for measuring multiplex chemiluminescent immunoassays.
Quanterix's products also include a comprehensive range of assays, which comprise all necessary components to run enzyme-based immunoassays, such as beads, capture and detector reagents, enzyme reagents, and substrates. Furthermore, the company provides replacement parts, reagents, and antibodies to support researchers and clinicians in their work.
Beyond its product offerings, Quanterix provides contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. These services cater to various fields, including neurology, oncology, cardiology, infectious diseases, and inflammation.
Quanterix primarily targets the life science research sector, selling its products to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies. The company's sales strategy involves a direct field sales approach, supported by organizations and distributors or sales agents.
Founded in 2007 as Digital Genomics, Inc., the company changed its name to Quanterix Corporation in August of the same year. Headquartered in Billerica, Massachusetts, Quanterix continues to drive innovation in the life sciences industry. For more information, visit their website at https://www.quanterix.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for QTRX - Quanterix - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/QTRX.NASDAQ_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for QTRX - Quanterix - Stock Price & Dividends](https://www.valueray.com/images/chart/QTRX.NASDAQ_seasonality.png)
QTRX Stock Overview
Market Cap in USD | 505m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2017-12-07 |
QTRX Stock Ratings
Growth 5y | -48.4 |
Fundamental | -49.6 |
Dividend | 0.00 |
Rel. Performance vs Sector | -8.37 |
Analysts | 4.20/5 |
Fair Price Momentum | 9.27 USD |
Fair Price DCF | - |
QTRX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
QTRX Growth Ratios
Growth 12m | -51.12% |
Growth Correlation 12m | -77% |
Growth Correlation 3m | -37% |
CAGR 5y | -12.31% |
CAGR/Mean DD 5y | -0.23 |
Sharpe Ratio 12m | -0.92 |
Alpha vs SP500 12m | -90.72 |
Beta vs SP500 5y weekly | 1.93 |
ValueRay RSI | 22.51 |
Volatility GJR Garch 1y | 69.29% |
Price / SMA 50 | -10.52% |
Price / SMA 200 | -38.67% |
Current Volume | 261.6k |
Average Volume 20d | 451k |
External Links for QTRX Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of September 08, 2024, the stock is trading at USD 11.99 with a total of 261,595 shares traded.
Over the past week, the price has changed by -7.98%, over one month by -9.98%, over three months by -23.24% and over the past year by -50.70%.
According to ValueRays Forecast Model, QTRX Quanterix will be worth about 10.5 in September 2025. The stock is currently trading at 11.99. This means that the stock has a potential downside of -12.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 20.4 | 70.4 |
Analysts Target Price | 30 | 150 |
ValueRay Target Price | 10.5 | -12.5 |